| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0001 |